Rapid Micro Biosystems Inc (RPID)
1.25
-0.02
(-1.57%)
USD |
NASDAQ |
Nov 12, 16:00
1.25
0.00 (0.00%)
After-Hours: 20:00
Rapid Micro Biosystems Revenue (Quarterly): 7.604M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 7.604M |
| June 30, 2024 | 6.618M |
| March 31, 2024 | 5.611M |
| December 31, 2023 | 6.337M |
| September 30, 2023 | 6.145M |
| June 30, 2023 | 5.002M |
| March 31, 2023 | 5.035M |
| December 31, 2022 | 4.374M |
| September 30, 2022 | 4.739M |
| June 30, 2022 | 3.86M |
| Date | Value |
|---|---|
| March 31, 2022 | 4.16M |
| December 31, 2021 | 5.208M |
| September 30, 2021 | 6.899M |
| June 30, 2021 | 6.13M |
| March 31, 2021 | 4.995M |
| December 31, 2020 | 5.238M |
| September 30, 2020 | 5.247M |
| June 30, 2020 | 2.593M |
| March 31, 2020 | 2.999M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.593M
Minimum
Jun 2020
7.604M
Maximum
Sep 2024
5.200M
Average
5.208M
Median
Dec 2021
Revenue (Quarterly) Benchmarks
| Standard BioTools Inc | 44.97M |
| Ainos Inc | -- |
| Zomedica Corp | 6.131M |
| LENSAR Inc | 12.64M |
| Intelligent Bio Solutions Inc | 0.7278M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.32M |
| Total Expenses (Quarterly) | 19.64M |
| EPS Diluted (Quarterly) | -0.26 |
| Enterprise Value | -7.189M |
| Gross Profit Margin (Quarterly) | 8.18% |
| Profit Margin (Quarterly) | -148.9% |
| Earnings Yield | -89.60% |
| Normalized Earnings Yield | -89.60 |